Skip to main content

PerkinElmer Value Stock - Dividend - Research Selection

Perkinelmer

ISIN: US7140461093 , WKN: 850943

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment develops and offers analytical technologies, solutions, and services for the environmental market that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. It also provides solutions to farmers and food producers; an analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries; and laboratory services. In addition, this segment offers a suite of solutions comprising reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market. The Diagnostics segment provides instruments, reagents, and software test and screen products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used in diagnosing genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in applications covering oncology, genetic testing, and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. has a collaboration agreement with Helix. The company was founded in 1931 and is headquartered in Waltham, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


1 Oversold Stock Primed to Rebound and 2 We Brush Off

2025-09-12
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Revvity, Inc. (RVTY) Launches its New In Vivo Imaging Center of Excellence

2025-09-10
Revvity, Inc. (NYSE:RVTY) is included in our list of the 14 Tech Stocks to Sell Now According to Ken Fisher. Revvity, Inc. (NYSE:RVTY) launched its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina’s Research Triangle, on September 2, 2025. With this launch, the company consolidates its expertise to accelerate next-generation imaging innovation. […]

Revvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

2025-09-09
Get the latest on Revvity's 2025 performance, market challenges, software growth, and

Revvity (RVTY): Evaluating the Stock’s True Value After Its New Imaging Innovation Center Launch

2025-09-08
Revvity (RVTY) just opened the doors of its new In Vivo Imaging Center of Excellence in North Carolina’s Research Triangle, bringing together its software, hardware, and biology teams under one roof. With this move, the company aims to accelerate the development of imaging systems that leverage AI and advanced technologies, positioning itself at the intersection of research innovation and practical problem-solving for disease science. For investors watching Revvity, this strategic push may...

Revvity (RVTY) Stock Trades Down, Here Is Why

2025-09-03
Shares of life sciences company Revvity (NYSE:RVTY) fell 5.1% in the afternoon session after several analyst firms lowered their price targets on the stock, pushing shares to a 52-week low. The negative sentiment comes despite a recent second-quarter earnings report where Revvity surpassed analyst expectations for both revenue and earnings per share. However, firms including Stifel, Raymond James, and Jefferies cut their price targets. Analysts cited ongoing challenges in China, including pressu

Revvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

2025-09-03
Get key takeaways from Revvity’s 2025 outlook, including growth drivers, China headwinds,

Why Revvity (RVTY) Stock Is Trading Lower Today

2025-09-02
Shares of life sciences company Revvity (NYSE:RVTY) fell 3.1% in the afternoon session after the major indices continued to retreat (Nasdaq -1.5%, S&P 500 -1.2%) amid profit-taking and renewed concerns about tariffs.

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

2025-09-02
WALTHAM, Mass., September 02, 2025--Revvity, Inc. (NYSE: RVTY), today announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, the heart of the state’s Research Triangle. The center consolidates Revvity’s expertise and resources to drive R&D innovation and create the next generation of imaging systems backed by AI software tools and other advanced technologies.

Shareholders in Revvity (NYSE:RVTY) are in the red if they invested three years ago

2025-09-01
Many investors define successful investing as beating the market average over the long term. But its virtually certain...

Are Wall Street Analysts Predicting Revvity Stock Will Climb or Sink?

2025-08-29
Diagnostics company Revvity has been underperforming the broader market. Are analysts still bullish about its stock?